World bank group and university of birmingham, Public university in Bristol, England

London, June 15 Two doses of Pfizer and AstraZeneca's Covid-19 vaccines are highly effective against hospitalisation from the Delta (B16172) variant, according to new analysis from Public Health England (PHE).The analysis suggests that the Pfizer-BioNTech vaccine is 96 per cent effective against hospitalisation after two doses, while the Oxford-AstraZeneca vaccine is 92 per cent effective against hospitalisation after two doses.These are comparable with vaccine effectiveness against hospitalisation from the Alpha (B117) variant: 96 per cent after two doses with Pfizer vaccine and 92 per cent after two doses from AstraZeneca vaccines.The new analysis included 14,019 cases of the Delta variant, 166 of whom were hospitalised between 12 April and 4 June, looking at emergency hospital admissions in England. The results have been posted as a preprint. Preprints are yet to be peer-reviewed."This evidence of the effectiveness of two doses against variants shows just how crucial it is to get your second jab. If you have had your first dose but haven't booked your second yet please do so. It will help save lives and boost us on the road to recovery," said Health and Social Care Secretary Matt Hancock, in a statement."These hugely important findings confirm that the vaccines offer significant protection against hospitalisation from the Delta variant. The vaccines are the most important tool we have against Covid-19. Thousands of lives have already been saved because of them. It is absolutely vital to get both doses as soon as they are offered to you, to gain maximum protection against all existing and emerging variants," added Dr Mary Ramsay, Head of Immunisation at PHE.A study by PHE in May showed that three weeks after the first dose of both Pfizer and AstraZeneca's coronavirus vaccine provided only 33 per cent protection against the Delta variant, while it offered 50 per cent effectiveness against the Alpha variant.The B16172 variant was first discovered in India and is one of three related strains. It was declared as a variant of global concern last month by the World Health Organization (WHO). It is 60 per cent more transmissible than the Alpha strain identified in the UK.Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

World Bank Group And University Of BirminghamFOLLOW

World bank group and university of birmingham, Latest News

Shafali Verma hit a half-century in the second innings of the ongoing one-off Test, but England remained in a dominant position here at the County Ground, Bristol. ...

Ageas Bowl (Hampshire), June 17 Since the maiden Test match between the inventors of the game, England and ... ...

From being skipper Virat Kohli's go-to-guy in limited-overs cricket to not finding a place regularly in the playing XI, Kuldeep Yadav has had a tough ride in the last couple of seasons. ...

England Women's cricket team captain Heather Knight won the toss and opted to bat against India in the one-off Test in the County Ground in Bristol on Wednesday. A deserved debut in red-ball cricket for young and aggressive Shafali Verma from the Ind ...

London, June 15 South African pace bowler Kagiso Rabada too could withdraw from The Hundred, to be organised ... ...

The England and Wales Cricket Board (ECB) on Tuesday said that they are disappointed to not be able to provide a fresh pitch for the upcoming women's Test between England and India, beginning Wednesday. ...

England assistant coach Graham Thorpe has said that the younger guys within the team squad need to improve and also need to develop their game. ...

London, June 15 Two doses of Pfizer and AstraZeneca's Covid-19 vaccines are highly effective against hospitalisation from the ... ...